Health Condition 1: N186- End stage renal disease
Conditions
Interventions
Intervention1: Ferric Citrate Vs. Sevelamer Carbonate: 1) All patients will be explained in detail the study design. They will be enrolled after signing the written informed consent form. After inform
Sponsors
Christian Medical College and Hospital, Ludhiana
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 18 years and above 2. Patients of both genders will be included in the study 3. Patients with the diagnosis of chronic kidney disease undergoing hemodialysis for at least 6 weeks 4. Elevated baseline serum phosphorus ( > 5.5 mg/dl)
Exclusion criteria
Exclusion criteria: 1. Significant gastrointestinal disorder (including known active peptic ulcer, Crohnâ??s disease, ulcerative colitis, irritable bowel syndrome, GI motility disorder) 2. Current malignancy 3. Pregnant and lactating women 4. Known hypersensitivity to phosphate binders 5. Other drugs affecting phosphorus metabolism (steroids, alcohol intake and use of other phosphate binders)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To compare the efficacy of ferric citrate with sevelamer carbonate as a phosphate binder in patients with chronic kidney disease on maintenance hemodialysis. 2. To compare the safety of ferric citrate with sevelamer carbonate as a phosphate binder in patients with chronic kidney disease on maintenance hemodialysis. Timepoint: 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Not decided yetTimepoint: Not applicable | — |
Countries
India
Contacts
Public ContactEesha
CMC Hospital Ludhiana
Outcome results
None listed